However, its crucial to clarify that the research on BPC-157 for use in humans is still in its infancy, with most of the peptide's potential benefits based on the results of animal or cell studies
It's also worth noting that the research picture on GLP-1s and bone is still evolving
(Tirzepatide + HT about 17% vs
See the randomized glutathione trial, NIH evidence summary, and 2025 skin-lightening systematic review
1 In the Surpass-Early trial, nearly 800 adults diagnosed with type 2 diabetes within the past four years were assigned to add either tirzepatide, sold as 1 Most patients in the control group received other GLP-1 drugs including semaglutide, sold by Novo Nordisk as Ozempic and Rybelsus, or Lilly's own dulaglutide
Protective effect of cinnamaldehyde against glutamate-induced oxidative stress and apoptosis in PC12 cells